Fujian Wanchen Biotechnology Co., Ltd reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 201.51 million compared to CNY 165.48 million a year ago. Revenue was CNY 201.52 million compared to CNY 165.48 million a year ago.

Net income was CNY 1.78 million compared to net loss of CNY 12.77 million a year ago. Basic earnings per share from continuing operations was CNY 0.0116 compared to basic loss per share from continuing operations of CNY 0.0832 a year ago. Diluted earnings per share from continuing operations was CNY 0.0116 compared to diluted loss per share from continuing operations of CNY 0.0832 a year ago.